Prostatype Genomics AB (publ) (PGABF)

Prostatype Genomics AB Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 6, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	11	7	1	5	15	23
Market Cap Growth	86.40%	495.90%	-75.73%	-68.84%	-35.03%	-
Enterprise Value	9	7	0	3	12	23
PS Ratio	144.51	38.80	3.04	70.95	53.75	62.69
PB Ratio	2.83	2.22	0.46	1.85	3.76	6.67
P/TBV Ratio	12.97	2.42	0.46	1.85	3.76	6.69
EV/Sales Ratio	117.68	37.87	0.09	43.91	43.72	63.10
Debt / Equity Ratio	-	0.00	0.47	0.03	0.04	0.05
Net Debt / Equity Ratio	-0.35	-0.28	0.36	-0.41	-0.53	-0.51
Net Debt / EBITDA Ratio	0.31	0.23	-0.23	0.37	1.23	1.19
Net Debt / FCF Ratio	0.33	0.21	-0.31	0.38	1.19	1.28
Asset Turnover	0.02	0.04	0.09	0.02	0.07	-
Inventory Turnover	119.10	150.03	103.02	74.11	29.43	-
Quick Ratio	1.93	1.24	0.16	3.15	6.12	3.90
Current Ratio	1.95	1.39	1.06	3.27	6.29	4.05
Return on Equity (ROE)	-182.06%	-141.21%	-163.05%	-93.74%	-48.69%	-
Return on Assets (ROA)	-68.19%	-56.00%	-61.19%	-50.40%	-26.31%	-
Return on Capital Employed (ROCE)	-113.80%	-122.10%	-158.60%	-107.80%	-42.30%	-41.70%
Earnings Yield	-43.85%	-55.16%	-365.11%	-60.02%	-11.59%	-7.26%
FCF Yield	-37.83%	-60.46%	-257.41%	-57.15%	-11.92%	-5.97%
Buyback Yield / Dilution	-2474.32%	-1645.51%	-343.99%	-28.75%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.